Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
24 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Panacea Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Panacea Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Panacea Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Panacea Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Panacea Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Panacea Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Panacea Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate Panacea Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Panacea Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Panacea Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Panacea Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Panacea Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Panacea Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Panacea Pharmaceuticals, Inc. Snapshot 5 Panacea Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Panacea Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Panacea Pharmaceuticals, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Panacea Pharmaceuticals, Inc. - Pipeline Products Glance 10 Panacea Pharmaceuticals, Inc. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Panacea Pharmaceuticals, Inc. - Unknown Stage Pipeline Products 11 Unknown Products/Combination Treatment Modalities 11 Panacea Pharmaceuticals, Inc. - Drug Profiles 12 PAN-22 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 PAN-622 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 PAN-811 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Small Molecules For Alzheimers Disease 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Panacea Pharmaceuticals, Inc. - Pipeline Analysis 18 Panacea Pharmaceuticals, Inc. - Pipeline Products by Target 18 Panacea Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 19 Panacea Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 20 Panacea Pharmaceuticals, Inc. - Dormant Projects 21 Panacea Pharmaceuticals, Inc. - Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 24 Disclaimer 24
List of Tables Panacea Pharmaceuticals, Inc., Key Information 5 Panacea Pharmaceuticals, Inc., Key Facts 5 Panacea Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7 Panacea Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8 Panacea Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9 Panacea Pharmaceuticals, Inc. - Preclinical, 2014 10 Panacea Pharmaceuticals, Inc. - Unknown, 2014 11 Panacea Pharmaceuticals, Inc. - Pipeline by Target, 2014 18 Panacea Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 19 Panacea Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 20 Panacea Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 21
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.